Stocks and Investing
Stocks and Investing
Fri, December 3, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jack Allen Initiated (VOR) at Buy and Held Target at $38 on, Dec 3rd, 2021
Jack Allen of Baird, Initiated "Vor Biopharma Inc." (VOR) at Buy and Held Target at $38 on, Dec 3rd, 2021.
Jack has made no other calls on VOR in the last 4 months.
There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 0 agree with Jack's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jack
- Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $30 on, Thursday, December 2nd, 2021
- Silvan Tuerkcan of "JMP Securities" Initiated at Buy and Held Target at $40 on, Tuesday, October 19th, 2021
Contributing Sources